Managing bipolar disorder or major depressive disorder during pregnancy requires careful consideration of lithium, a well established mood stabilizer. For people with lithium dependent bipolar disorder, stopping medication can trigger a relapse of symptoms, yet continuing use raises questions about potential risks to the developing baby. Modern clinical practice emphasizes shared decision making, using the best available evidence to balance the benefits of mood stabilization for the parent against any possible lithium in pregnancy effects on the fetus. Close collaboration between a psychiatrist, an obstetrician, and often a perinatal mental health specialist helps create a safety focused plan tailored to the individual.
How Lithium Works and Why It Is Used in Pregnancy
Lithium modulates neurotransmitters, stabilizes neuronal firing, and influences intracellular signaling pathways, which together reduce the frequency and severity of manic and depressive episodes. For many people with bipolar disorder, lithium is the most effective agent for preventing both manic and depressive relapses, decreasing hospitalizations, and supporting daily functioning. During pregnancy, the goal is to maintain emotional stability, because untreated maternal mood episodes themselves carry significant risks, including poor prenatal care adherence, substance use, and stress that can affect fetal development. Prescribing lithium in pregnancy therefore focuses on optimizing control at the lowest effective dose while monitoring maternal and fetal wellbeing closely.
Lithium Use in Each Trimester and Key Considerations
First Trimester Concerns
Organogenesis occurs primarily in the first trimester, a period when teratogenic risks are most relevant. Some studies suggest a small absolute increase in cardiac malformations, particularly Ebstein anomaly, though the baseline risk is low and estimates vary widely. Many clinicians obtain detailed fetal echocardiography around 18 to 22 weeks to evaluate cardiac anatomy if lithium is continued. Decisions about whether to continue, adjust, or discontinue lithium often weigh the severity of the parent’s illness, prior response to medication, and available psychosocial support.
Second and Third Trimester Focus
After the first trimester, attention shifts to lithium in pregnancy pharmacokinetics and neonatal effects. Renal and hemodynamic changes in pregnancy can alter lithium clearance, sometimes requiring dose adjustments to maintain therapeutic levels. Near delivery, lithium levels are monitored more frequently to avoid toxicity, especially if dehydration or changes in salt intake occur. Planning for the immediate postpartum period is important, as rapid dose changes and sleep deprivation can increase relapse risk.
Monitoring and Safety Strategies During Pregnancy
Regular monitoring of lithium levels, renal function, and thyroid status is essential throughout pregnancy and the postpartum period. Hydration and sodium intake should be consistent, because fluctuations can affect serum lithium concentrations. Many teams obtain a baseline fetal echocardiogram and serial growth ultrasounds to detect any structural or growth concerns early. Collaborative care between mental health and obstetric providers ensures that warning signs, such as tremor, confusion, or excessive fatigue, are recognized and managed promptly.
Delivery Planning and Postpartum Management
Delivery planning includes discussing preferred birth settings, pain management options, and how to maintain stable lithium levels during labor, especially if oral intake is temporarily reduced. Some clinicians maintain lithium at therapeutic levels close to delivery and restart it once the parent is able to take medications reliably and is monitored closely. In the immediate postpartum, sleep disruption, hormonal shifts, and the stress of new parenthood heighten vulnerability, so extra support and frequent contact with the treatment team are valuable components of lithium in pregnancy care.
Lithium in Breastfeeding and Lactation Considerations
Lithium passes into breast milk, so decisions about breastfeeding while taking lithium involve weighing infant exposure against the benefits of breastfeeding for both parent and baby. Infants exposed to lithium should be monitored for lethargy, poor feeding, or irritability, and serum lithium levels may be checked if there are concerns. Many families successfully breastfeed while taking lithium, particularly when levels are drawn just before a feeding and dosing is adjusted to minimize peak milk concentrations.
